Bryan Roberts
Bryan Roberts is a Partner at Venrock, a venture capital firm based in Palo Alto, California, where he has worked since 1997. He focuses on early-stage investments across healthcare and life sciences, with current and past portfolio companies including Illumina, athenahealth, 10x Genomics, Aledade, Devoted Health, and Kelonia Therapeutics. He holds a Ph.D. in Chemistry and Chemical Biology from Harvard University and a B.A. from Dartmouth College.
“Kelonia's last round was a Series A in 2022 at a $104 million post-money valuation — making the $3.25B upfront (and up to $7B total) a staggering markup”
“M&A in 2026 feels pretty hot. The obesity wave is creating opportunity and cash flow—and fear about what happens post. — Bryan Roberts, Venrock partner”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.